Concord Medical Services Holdings Income Statement (2009-2025) | CCM

Income Statement Mar2009 Jun2009 Sep2009 Dec2009 Mar2010 Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Dec2016 Jun2017 Dec2017 Jun2018 Dec2018 Jun2019 Dec2019 Jun2020 Dec2020 Jun2021 Dec2021 Jun2022 Dec2022 Jun2023 Dec2023 Jun2024 Dec2024 Jun2025 Dec2025
Revenue & cost
Revenue (Quarter)
19.88M30.42M15.88M14.50M11.75M29.88M21.54M39.24M30.11M28.00M
Cost of Revenue (Quarter)
6.35M4.50M1.60M1.58M3.13M2.12M3.94M3.63M3.44M2.93M
Gross Profit (Quarter)
8.61M10.51M3.62M0.46M-0.49M0.37M-13.25M-5.16M-5.72M-0.60M
Operating items
Amortization - Intangibles (Quarter)
Selling, General & Administrative (Quarter)
-11.58M-17.08M-17.28M-20.32M-19.02M-26.74M-19.48M-20.72M-18.05M-16.66M
Other Operating Expenses (Quarter)
Operating Expenses (Quarter)
-11.58M-16.88M-17.95M-20.47M-19.02M-26.74M-19.78M-21.45M-18.12M-16.50M
Operating Income (Quarter)
-2.35M-11.07M-15.27M-21.45M-22.64M-28.48M-36.67M-29.52M-27.21M-20.19M
EBIT (Quarter)
-2.35M-10.94M-15.86M-21.60M-22.64M-28.48M-37.25M-30.56M-27.32M-20.00M
Non-operating items
Non Operating Investment Income (Quarter)
6.61M
Interest & Investment Income (Quarter)
3.17M0.99M0.78M0.89M0.57M0.39M0.53M0.80M0.82M0.64M
Other Non Operating Income (Quarter)
0.47M1.42M1.68M0.38M-0.25M0.41M-0.13M1.88M-4.17M-0.27M
Non Operating Income (Quarter)
0.34M0.39M0.70M1.95M0.19M-0.12M
Net income details
EBT (Quarter)
-5.51M-13.06M-18.43M-22.21M-23.23M-27.42M-40.59M-32.24M-46.43M-25.91M
Tax Provisions (Quarter)
-2.37M-2.34M-0.90M-1.15M-0.26M0.83M1.45M3.23M1.19M-2.76M
Profit After Tax (Quarter)
-7.87M-15.40M-19.32M-23.36M-23.49M-26.59M-39.14M-29.01M-45.23M-28.67M
Equity Income (Quarter)
-0.67M1.15M1.41M0.82M1.39M0.83M1.04M
Net Income - Minority (Quarter)
-9.61M-12.22M-16.79M
Investment Income (Quarter)
-0.74M0.45M0.72M
Income from Non-Controlling Interests (Quarter)
0.12M-0.14M-0.09M-2.79M-5.26M-12.60M-22.03M-16.46M-21.53M-24.88M
Income from Continuing Operations (Quarter)
-3.14M-10.60M-18.20M-21.21M-22.97M-28.24M-42.69M-36.72M-47.80M-22.92M
Consolidated Net Income (Quarter)
-3.14M-10.60M-18.20M-21.21M-22.97M-28.24M-42.69M-36.72M-47.80M-22.92M
Income towards Parent Company (Quarter)
-3.14M-9.61M-10.60M-12.22M-18.20M-16.79M-21.21M-22.97M-28.24M-42.69M-36.72M-47.80M-22.92M
Net Income towards Common Stockholders (Quarter)
-7.72M-9.61M-15.01M-12.22M-19.36M-16.79M-21.21M-22.97M-28.24M-42.69M-36.72M-47.80M-22.92M
Additional items
EPS (Basic) (Quarter)
-0.18-0.50-0.34-0.62-191.53-0.89
EPS (Weighted Average and Diluted) (Quarter)
-0.18-0.50-0.34
Shares Outstanding (Weighted Average) (Quarter)
0.02M19.15M0.02M19.66M0.02M18.82M18.48M19.78M20.50M18.43M18.20M18.24M18.48M
Shares Outstanding (Diluted Average) (Quarter)
19.15M19.78M20.50M18.43M18.20M18.24M18.48M
EBITDA (Quarter)
-8.61M-14.95M-18.60M-23.42M-24.46M-25.62M-45.40M-31.40M-46.09M-27.70M
Tax Rate (Quarter)
42.98%17.90%4.88%5.19%1.11%-3.01%-3.56%-10.02%-2.57%10.66%